Merck & Co said on Wednesday it will supply about 60,000-100,000 doses of its COVID-19 treatment to the U.S. government for up to about US$356 million.
Merck & Co said on Wednesday it will supply about 60,000-100,000 doses of its COVID-19 treatment to the U.S. government for up to about US$356 million.